Skip to main content
All lobbying filings

W STRATEGIES, LLC

Lobbying for GILEAD SCIENCES, INC. · American biotechnology company that researches, develops and commercializes drugs.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income · posted Apr 18, 2025

Official filing document

 Bills named in this filing 2
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
  • HR 5376
    Impacts and Outcomes for Health Career Training Act
 Lobbying activity 2
Health Issues

Education about access to HIV medicines Education about the 340(b) program.

Medicare/Medicaid

H.R.1492 - EPIC Act. Implementation H.R.5376 - Inflation Reduction Act of 2022.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem